New HIV Vaccine Strategy Achieves Proof-Of-Principle (IMAGE)

Scripps Research Institute

New HIV Vaccine Strategy Achieves Proof-Of-Principle

Caption

Scientists at Scripps Research were part of a team that designed and tested a new vaccine candidate (green and blue) that binds to precursors of HIV broadly neutralizing antibodies (tan) and has promise as the first stage of an HIV vaccine.

Credit

The Schief Laboratory at Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.